Safety and Efficacy of 8 Weeks Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 4 in Children Aged 4-10 Years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Efficacy of 8 Weeks Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 4 in Children Aged 4-10 Years

Published:2020-04 Issue: Volume:219 Page:106-110
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Behairy Behairy E.,El-Araby Hanaa A.,El-Guindi Mohamed A.,Basiouny Hosam-Eldin M.,Fouad Ola A.,Ayoub Bassam A.,Marei Ayman M.,Sira Mostafa M.

Funder

National Liver Institute

Menoufia University

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference27 articles.

1. Global distribution and prevalence of hepatitis C virus genotypes;Messina;Hepatology,2015

2. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations;Omran;World J Gastroenterol,2018

3. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity;Habib;Hepatology,2001

4. Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children;El-Raziky;World J Gastroenterol,2007

5. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of DAA in children and adolescents with chronic HCV infection: A systematic review and meta‐analysis;Liver International;2024-01-31

2. Viral Infections of the Fetus and Newborn;Avery's Diseases of the Newborn;2024

3. Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities—A Brief Report;Infectious Disease Reports;2022-08-03

4. Safety and Efficacy of Ledipasvir/Sofosbuvir in the Treatment of Chronic Hepatitis C Virus Infection in Treatment-Naïve Children without and with Comorbidities;Pediatric Drugs;2022-07-15

5. Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project;Journal of Clinical Medicine;2021-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3